LHRH, N-Ac-(4-Cl-Phe)(1,2)-Trp(3)-Arg(6)-AlaNH2(10)-: suppresses ovulation; gonadorelin antagonist [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 25078109 |
MeSH ID | M0109517 |
Synonym |
---|
gnrh, n-ac-(4-cl-phe)(1,2)-trp(3)-arg(6)-alanh2(10)- |
81608-49-3 |
napt-taa |
axe8h8vy6h , |
d-alaninamide, n-acetyl-4-chloro-d-phenylalanyl-4-chloro-d-phenylalanyl-d-tryptophyl-l-seryl-l-tyrosyl-d-arginyl-l-leucyl-l-arginyl-l-prolyl- |
unii-axe8h8vy6h |
lhrh-n-acetyl-4-chlorophenylalanyl(1,2)-tryptophyl(3)-arginyl(6)-alaninamide |
1-n-ac-1,2-(4-cl-phe)-3-trp-6-arg-10-alanh2-lhrh |
lhrh, n-ac-(4-cl-phe)(1,2)-trp(3)-arg(6)-alanh2(10)- |
DTXSID10231222 |
(ac-d-p-cl-phe1,2,d-trp3,d-arg6,d-ala10)-lh-rh |
org-30276 amide |
(acetyl-d-p-cl-phe1,2,d-trp3,d-arg6,d-ala10)-lh-rh |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 13 (92.86) | 18.7374 |
1990's | 1 (7.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.56) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 14 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |